David P. Schenkein - 01 Jun 2021 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role: Director
Signature: /s/ Tyler Nielsen, by power of attorney
Issuer symbol: DNLI
Transactions as of: 01 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 03 Jun 2021, 20:57:14 UTC
Previous filing: 02 Jun 2021
Next filing: 04 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DNLI	Common Stock	Options Exercise	$0	+3,253		$0.000000	3,253	01 Jun 2021	Direct
holding	DNLI	Common Stock						26,232	01 Jun 2021	See footnote	F1
holding	DNLI	Common Stock						31,232	01 Jun 2021	See footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DNLI	Restricted Stock Units	Options Exercise	$0	-3,253	-100%	$0.000000^*	0	01 Jun 2021	Common Stock	3,253		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held of record by the David P. Schenkein 2004 Revocable Trust, for which the Reporting Person serves as a trustee.
F2	The shares are held of record by the Amy P. Schenkein 2004 Revocable Trust, for which the Reporting Person's spouse serves as a trustee.
F3	Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
F4	100% of the restricted stock units shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.